Timolol 0.1% in Glaucomatous Patients: Efficacy, Tolerance, and Quality of Life
Glaucoma is a progressive, chronic optic neuropathy characterized by a typical visual field defects. Four main classes of topical medication are actually available on the market: beta-blockers, prostaglandins, alpha2-agonists, and topical carbonic anhydrase inhibitor to treat intraocular pressure (I...
Saved in:
| Main Authors: | Letizia Negri, Antonio Ferreras, Michele Iester |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2019-01-01
|
| Series: | Journal of Ophthalmology |
| Online Access: | http://dx.doi.org/10.1155/2019/4146124 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effect of dorzolamide compared with timolol maleate on the central corneal thickness and endothelial-cell count of glaucomatous eyes
by: Ernesto D. Golez III, MD, et al.
Published: (2007-12-01) -
Efficacy and Tolerability of Travoprost 0.004%/Timolol 0.5% Fixed-Dose Combination for the Treatment of Primary Open-Angle Glaucoma or Ocular Hypertension Inadequately Controlled with Beta-Blocker Monotherapy
by: Simon Fabian Lerner, et al.
Published: (2017-01-01) -
Adjunctive antihypertensive therapy of primary glaucoma with a fixed combination drug of 1% brinzolamide and 0.5% timolol: efficacy and safety
by: S. Yu. Petrov, et al.
Published: (2023-07-01) -
Temperature- and water-induced structural transformations in Ba(Ce0.7Zr0.1Y0.1Yb0.1)O3-δ proton conducting electrolyte
by: Ivan Ivanov, et al.
Published: (2024-12-01) -
Divisive Refinement of Metal Fiber at the PM0.1 Classification Stage for PM0.5–0.1 Sampling with Nanosampler
by: Yuta Kurotsuchi, et al.
Published: (2023-03-01)